AnaptysBio to split into two public companies: one for royalty management, the other for immunology drug development. Read more here.
Marathon season’s firmly here, baby. Sydney and Berlin went down over the last few weeks, and Chicago and New York are on the horizon, along with some important non-majors: Amsterdam, Lisbon, ...